ZURELIDY
Live / Applied — Third extension granted (statement of use) (as of 02 Dec 2025)
What this means for you
Not registered yet, but its 05 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98165258
- Mark type
- Stylized text
- Filed
- 05 Sept 2023
- Published for opposition
- 04 Jun 2024
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Radiopharmaceutical product for the treatment of cancer; pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of metastatic castration resistant prostate cancer
Owner
- Lantheus Medical Imaging, Inc., North Billerica, MA, US
- Lantheus Medical Imaging, Inc., North Billerica, MA, US
Prosecution history
- 03 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2025 — SOU EXTENSION 3 GRANTED
- 02 Dec 2025 — SOU EXTENSION 3 FILED
- 02 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jul 2025 — SOU EXTENSION 2 GRANTED
- 17 Jul 2025 — SOU EXTENSION 2 FILED
- 17 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jan 2025 — SOU EXTENSION 1 GRANTED
- 02 Jan 2025 — SOU EXTENSION 1 FILED
- 02 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jun 2024 — PUBLISHED FOR OPPOSITION